Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · IEX Real-Time Price · USD
2.050
+0.010 (0.49%)
Mar 28, 2024, 4:30 PM EDT - Market closed

Checkpoint Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
0.10.190.271.071.713.511.732.570.59
Revenue Growth (YoY)
-46.35%-28.36%-74.93%-37.41%-51.28%103.25%-32.88%335.59%-
Gross Profit
0.10.190.271.071.713.511.732.570.59
Selling, General & Admin
8.698.78.547.927.236.595.424.472.49
Research & Development
43.5749.8348.4516.3519.3333.6519.0820.2711.32
Operating Expenses
52.2558.5356.9924.2726.5640.2524.524.7313.81
Operating Income
-52.15-58.33-56.72-23.2-24.85-36.74-22.78-22.16-13.22
Interest Expense / Income
00000000.340.24
Other Expense / Income
-0.34.29-0.05-0.12-0.14-0.37-0.1-0.050.44
Pretax Income
-51.85-62.62-56.67-23.08-24.71-36.37-22.68-22.46-13.89
Net Income
-51.85-62.62-56.67-23.08-24.71-36.37-22.68-22.46-13.89
Shares Outstanding (Basic)
1998643221
Shares Outstanding (Diluted)
1998643221
Shares Change
112.13%16.21%36.18%58.14%23.64%26.24%4.99%118.60%-
EPS (Basic)
-3.17-7.09-7.45-4.10-7.00-12.70-10.00-10.40-14.10
EPS (Diluted)
-3.17-7.09-7.45-4.10-7.00-12.70-10.00-10.40-14.10
Free Cash Flow
-47.59-57.55-26.31-16.55-21.37-25.81-15.46-9.95-1.11
Free Cash Flow Per Share
-2.54-6.51-3.46-2.96-6.05-9.04-6.83-4.62-1.12
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-50629.13%-30381.77%-21165.30%-2170.35%-1454.92%-1047.92%-1320.29%-862.41%-2240.85%
Profit Margin
-50336.89%-32616.67%-21145.52%-2159.12%-1446.96%-1037.28%-1314.61%-873.97%-2354.58%
Free Cash Flow Margin
-46203.88%-29976.04%-9815.67%-1548.27%-1251.35%-736.02%-896.29%-387.16%-187.80%
EBITDA
-51.85-62.62-56.67-23.08-24.71-36.37-22.68-22.12-13.66
EBITDA Margin
-50336.89%-32616.67%-21145.52%-2159.12%-1446.96%-1037.28%-1314.61%-860.58%-2314.75%
EBIT
-51.85-62.62-56.67-23.08-24.71-36.37-22.68-22.12-13.66
EBIT Margin
-50336.89%-32616.67%-21145.52%-2159.12%-1446.96%-1037.28%-1314.61%-860.58%-2314.75%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).